BioSpace News Archive

Pharm Country

Amarin Announces VAZKEPA® (icosapent ethyl) Approved by the Therapeutic Goods Administration (TGA) in Australia

Amarin Corporation plc (NASDAQ:AMRN) today announced that Australia’s Therapeutic Good Administration (TGA) has granted approval to VAZKEPA (icosapent ethyl).

November 15, 2022
·
4 min read
Business

Daewoong Pharmaceutical Surpasses KRW 300 Billion in Q3 Revenue as Nabota Sales Grew by 93%, Leading Overall Growth in Revenue

Daewoong Pharmaceutical Co., Ltd. (CEO Jeon Sengho, Lee Changjae) announced the third-quarter financial results.

November 15, 2022
·
4 min read
Biotech Bay

Veeva Pulse Shows Post-Pandemic HCP Access Nearing 80% in Key Specialties Driven by Digital Engagement

Veeva Systems (NYSE: VEEV) today released the latest Veeva Pulse Field Trends Report, the largest and most complete analysis of healthcare professional (HCP) access across the biopharma industry.

November 15, 2022
·
4 min read
Genetown

Casma Therapeutics Raises $46.0 M in Series C Funding

Casma Therapeutics, Inc. today announced the closing of a Series C financing round of $46.0 million.

November 15, 2022
·
2 min read
Deals

SEC Declares Form S-4 Registration Statement “Effective” for Proposed Business Combination of Larkspur Health Acquisition Corp., Inc. with ZyVersa Therapeutics, Inc.

Larkspur Health Acquisition Corp. and ZyVersa Therapeutics, Inc. are pleased to announce that Larkspur’s proxy/registration statement on Form S-4 filed with the U.S. Securities and Exchange Commission on August 12, 2022, as amended, was declared effective by the SEC on November 14, 2022.

November 15, 2022
·
11 min read
Genetown

BeiGene Launches Talk About It Program to Elevate the Importance of Addressing Mental Health during Cancer Care

BeiGene Launches Talk About It Program to Elevate the Importance of Addressing Mental Health during Cancer Care.

November 15, 2022
·
6 min read
BioForest

Bonum Therapeutics Announces a $93M Series A Financing to Advance a Novel and Validated Class of Conditionally Active Therapies

Bonum Therapeutics today announced a $93 million Series A financing.

November 15, 2022
·
3 min read
Business

Metabolon Signs New Partnership with UK’s Tracking Parkinson’s Study

Metabolon, Inc., the global leader in providing metabolomics solutions that advance a wide variety of research, diagnostic, therapeutic development, and precision medicine applications, today announced a new collaboration with Tracking Parkinson’s.

November 15, 2022
·
4 min read